Open Access. Powered by Scholars. Published by Universities.®
Antitrust and Trade Regulation Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Business (4)
- Business Organizations Law (2)
- Business and Corporate Communications (2)
- Labor and Employment Law (2)
- Banking and Finance Law (1)
-
- Business Administration, Management, and Operations (1)
- Business Intelligence (1)
- Business Law, Public Responsibility, and Ethics (1)
- Contracts (1)
- First Amendment (1)
- Health Law and Policy (1)
- Intellectual Property Law (1)
- International Business (1)
- International Law (1)
- International Trade Law (1)
- Legislation (1)
- Keyword
-
- Abstention defenses (1)
- American consumers (1)
- Anticompetitive Agreement (1)
- Big Tech (1)
- Comity (1)
-
- Corporate governance (1)
- Cost-benefit analysis (1)
- DEI (1)
- Discrimination (1)
- ESG (1)
- Empirical evidence (1)
- Employee speech (1)
- Entrepreneurship (1)
- Federal Trade Commission (1)
- Federal ban (1)
- First Amendment (1)
- Foreign defendants (1)
- Freedom of speech (1)
- Horizontal conspiracy (1)
- Import commerce (1)
- Intellectual Property (1)
- International comity grounds (1)
- International law (1)
- Investment (1)
- Jurisdiction (1)
- Low-wage workers (1)
- Non-compete agreements (1)
- Patent (1)
- Pharmaceutical (1)
Articles 1 - 5 of 5
Full-Text Articles in Antitrust and Trade Regulation
Is A Ban On Non-Competes Supported By Empirical Evidence?, Sarah Oh Lam, Thomas Lenard, Scott Wallsten
Is A Ban On Non-Competes Supported By Empirical Evidence?, Sarah Oh Lam, Thomas Lenard, Scott Wallsten
Fordham Journal of Corporate & Financial Law
The U.S. Federal Trade Commission (FTC) has proposed a rule to declare virtually all non-compete agreements unfair methods of competition under Section 5 of the FTC Act and therefore, illegal. However, the empirical literature on non-compete agreements cited by the FTC in its Notice for Proposed Rulemaking (“NPRM”) shows mixed results on earnings, job creation, firm formation, entrepreneurship, training, investment, and firm value. Evidence in other current studies also does not support an economy-wide ban. The FTC concludes that the proposed rule would yield net benefits even though by its own admission it lacks the information necessary to conduct a …
The Public’S Companies, Andrew K. Jennings
The Public’S Companies, Andrew K. Jennings
Fordham Journal of Corporate & Financial Law
This Essay uses a series of survey studies to consider how public understandings of public and private companies map into urgent debates over the role of the corporation in American society. Does a social-media company, for example, owe it to its users to follow the free-speech principles embodied in the First Amendment? May corporate managers pursue environmental, social, and governance (“ESG”) policies that could reduce short-term or long-term profits? How should companies respond to political pushback against their approaches to free expression or ESG?
The studies’ results are consistent with understandings that both public and private companies have greater public …
Divined Comity: Assessing The Vitamin C Antitrust Litigation And Updating The Second Circuit’S Prescriptive Comity Framework, William Weingarten
Divined Comity: Assessing The Vitamin C Antitrust Litigation And Updating The Second Circuit’S Prescriptive Comity Framework, William Weingarten
Fordham Journal of Corporate & Financial Law
In re Vitamin C Antitrust Litigation, recently decided by the Second Circuit, sets a grave precedent for American plaintiffs seeking redress for antitrust injuries wrought by foreign defendants. The case involved a group of Chinese manufacturers and exporters of vitamin C, who conspired to fix prices and restrict output in the export market, injuring American consumers in import commerce. The foreign manufacturers conceded that they had colluded in fixing prices and restricting output, in flagrant violation of U.S. antitrust law. And yet, with the assistance of the Chinese government—intervening as amicus curiae—the defendants were successfully able to argue, on appeal …
Renewing Faith In Antitrust: Unveiling The Hidden Network Behind Pharmaceutical Product Hopping, Victoria Field
Renewing Faith In Antitrust: Unveiling The Hidden Network Behind Pharmaceutical Product Hopping, Victoria Field
Fordham Journal of Corporate & Financial Law
Patents grant time-limited market exclusivity to drug manufacturers, meaning that other companies are prohibited from copying and selling the patented pharmaceutical. This allows manufacturers to lawfully charge monopoly prices. Generic competition starts at the expiration of the patent. To maintain coveted monopoly power, manufacturers often release an alternative formulation of the drug with a fresh patent that enjoys continued market exclusivity. Manufacturers who can convert their consumer base to the new formulation can continue charging peak prices. This process, called “product hopping,” has been the target of significant antitrust inquiry, with mixed results.
A product hop may be the result …
The Battle With Big Tech: Analyzing Antitrust Enforcement And Proposed Reforms, Youngjae Lee, Morgan Hagenbuch
The Battle With Big Tech: Analyzing Antitrust Enforcement And Proposed Reforms, Youngjae Lee, Morgan Hagenbuch
Fordham Journal of Corporate & Financial Law
No abstract provided.